Ignite Creation Date:
2024-05-06 @ 1:37 AM
Last Modification Date:
2024-10-26 @ 11:07 AM
Study NCT ID:
NCT01856894
Status:
COMPLETED
Last Update Posted:
2014-02-19
First Post:
2013-05-14
Brief Title:
Serum Anti-Mullerian Hormone AMH Levels in Overweight and Obese Adolescent Girls With Polycystic Ovaries
Sponsor:
Bakirkoy Dr Sadi Konuk Research and Training Hospital
Organization:
Bakirkoy Dr Sadi Konuk Research and Training Hospital
Study Overview
Official Title:
Is Serum Anti-Mullerian Hormone AMH Level Associated With Body Weight Glycemic and Lipidemic Markers in Adolescent Girls With Polycystic Ovaries
Status:
COMPLETED
Status Verified Date:
2014-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this study the investigators aimed to investigate whether there is a relation between body weight and serum anti mullerian hormone levels in adults with polycystic ovary syndrome For this purpose the investigators designed a prospective study including three groups The group I is defined as adults with polycystic ovary syndrome and body mass index is greater than 25 The group II is defined as adults with polycystic ovary syndrome and body mass index is less than 25 The group III is defined as adults with non-polycystic ovary syndrome and body mass index is less than 25 The all three groups are compared considering their serum AMH levelslipid profiles sex steroids and glycemic analyses
Detailed Description:
In this study the investigators aimed to investigate whether there is a relation between body weight and serum anti mullerian hormone levels in adults with polycystic ovary syndrome For this purpose the investigators designed a prospective study including three groups The diagnosis of polycystic ovary syndrome was made in the presence of oligo- andor anovulationclinical andor biochemical signs of hyperandrogenism and polycystic ovaries Clinical hyperandrogenism was defined by the presence of hirsutism acne or the presence of androgenic alopecia biochemical hyperandrogenemia was defined as a serum level of total testosterone higher than 260 nmolL body mass index BMI was calculated as weight in kilograms divided by the square of height in meters The patients were classified as obese with BMI 25 kgm2 adolescent patients were diagnosed 2 years after menarche in order to avoid the misdiagnosis of transitory functional hyperandrogenism and menstrual disorders during puberty The all three groups are compared considering their serum AMH levelslipid profiles sex steroids and glycemic analyses
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None